Cited by 444Treatment of Major DepressionTryptophan and brain disordersStress Responses and Cortisol

The DOI matches its Crossref record; 208 of the 212 references it cites were found in a registry or an index.

Biomarkers for depression: recent insights, current challenges and future prospects

Open access

Strawbridge, Rebecca, Young, Allan H, Cleare, Anthony J·2017·Neuropsychiatric Disease and Treatment

Open this paper in CoChat — free account Open PDF

Abstract

Abstract: A plethora of research has implicated hundreds of putative biomarkers for depression, but has not yet fully elucidated their roles in depressive illness or established what is abnormal in which patients and how biologic information can be used to enhance diagnosis, treatment and prognosis. This lack of progress is partially due to the nature and heterogeneity of depression, in conjunction with methodological heterogeneity within the research literature and the large array of biomarkers with potential, the expression of which often varies according to many factors. We review the available literature, which indicates that markers involved in inflammatory, neurotrophic and metabolic processes, as well as neurotransmitter and neuroendocrine system components, represent highly promising candidates. These may be measured through genetic and epigenetic, transcriptomic and proteomic, metabolomic and neuroimaging assessments. The use of novel approaches and systematic research programs is now required to determine whether, and which, biomarkers can be used to predict response to treatment, stratify patients to specific treatments and develop targets for new interventions. We conclude that there is much promise for reducing the burden of depression through further developing and expanding these research avenues. Keywords: mood disorder, major depressive disorder, inflammation, treatment response, stratification, personalized medicine

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2147/ndt.s114542

Cites

208 of 208 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Part of this paper’s reference list could not be split into single entries.

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Research domain criteria (RDoC): toward a new classification framework for research on mental disorders
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., & Wang, P. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09091379 · Cited by 7,067
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
No health without mental health
Prince, M. J., Patel, V., Saxena, S., Maj, M., Maselko, J., Phillips, M. R., & Rahman, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61238-0 · Cited by 4,028
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.12 · Cited by 2,627
Gut–brain axis: How the microbiome influences anxiety and depression
Foster, J. A., & McVey Neufeld, K.-A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.005 · Cited by 2,460
Depression and poor glycemic control: a meta-analytic review of the literature.
Lustman, P. J., Anderson, R. J., Freedland, K. E., de Groot, M., Carney, R. M., & Clouse, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.934 · Cited by 1,854
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression: The Role of Baseline Inflammatory Biomarkers
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Challenges of Big Data analysis
Fan, J., Han, F., & Liu, H. (2014) · National Science Review · doi:10.1093/nsr/nwt032 · Cited by 1,482
Visceral fat adipokine secretion is associated with systemic inflammation in obese humans
Fontana, L., Eagon, J. C., Trujillo, M. E., Scherer, P. E., & Klein, S. (2007) · Diabetes · doi:10.2337/db06-1656 · Cited by 1,417
Diagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380
The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis
Steptoe, A., Hamer, M., & Chida, Y. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.03.011 · Cited by 1,278
Childhood maltreatment predicts adult inflammation in a life-course study
Danese, A., Pariante, C. M., Caspi, A., Taylor, A., & Poulton, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610362104 · Cited by 1,264
Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
Adverse Childhood Experiences and Adult Risk Factors for Age-Related Disease: Depression, Inflammation, and Clustering of Metabolic Risk Markers
Danese, A., Moffitt, T. E., Harrington, H., Milne, B. J., Polanczyk, G., Pariante, C. M., Poulton, R., & Caspi, A. (2009) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.214 · Cited by 1,165
Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
Haapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.001 · Cited by 1,129
Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research
Stetler, C., & Miller, G. E. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31820ad12b · Cited by 1,123
A mega-analysis of genome-wide association studies for major depressive disorder
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke, S., Wray, N. R., Lewis, C. M., Hamilton, S. P., Weissman, M. M., Breen, G., Byrne, E. M., Blackwood, D. H. R., Boomsma, D. I., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.21 · Cited by 1,120
A Review of Accelerometry-Based Wearable Motion Detectors for Physical Activity Monitoring
Yang, C.-C., & Hsu, Y.-L. (2010) · Sensors · doi:10.3390/s100807772 · Cited by 1,058
Evidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?
Kapur, S., Phillips, A. G., & Insel, T. R. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.105 · Cited by 980
A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression
Brunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972
Interleukin (IL)-6, Tumour Necrosis Factor Alpha (TNF-α) and Soluble Interleukin-2 Receptors (SIL-2R) Are Elevated in Patients with Major Depressive Disorder: A Meta-Analysis and Meta-Regression
Liu, Y., Ho, R. C.-M., & Mak, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.003 · Cited by 948
Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder.
Hirschfeld, R. M. A., Lewis, L., & Vornik, L. A. (2003) · PubMed · Cited by 943
Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects: A Systematic Review and Meta-analysis of Randomized Clinical Trials
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
The macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931
HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition
Keller, J., Gomez, R., Williams, G., Lembke, A., Lazzeroni, L., Murphy, G. M., & Schatzberg, A. F. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.120 · Cited by 922
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
Hannestad, J., DellaGioia, N., & Bloch, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.132 · Cited by 914
Altered Gene Expression of Brain-Derived Neurotrophic Factor and Receptor Tyrosine Kinase B in Postmortem Brain of Suicide Subjects
Dwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.804 · Cited by 875
Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile
Penninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-129 · Cited by 839
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma
Nemeroff, C. B., Heim, C. M., Thase, M. E., Klein, D. N., Rush, A. J., Schatzberg, A. F., Ninan, P. T., McCullough, J. P., Weiss, P. M., Dunner, D. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336126100 · Cited by 829
The correlative triad among aging, dopamine, and cognition: Current status and future prospects
Bäckman, L., Nyberg, L. H., Lindenberger, U., Li, S., & Farde, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.06.005 · Cited by 795
Bidirectional Association Between Depression and Metabolic Syndrome
Pan, A., Keum, N., Okereke, O. I., Sun, Q., Kivimaki, M., Rubin, R. R., & Hu, F. B. (2012) · Diabetes Care · doi:10.2337/dc11-2055 · Cited by 772
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Self-citation
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
The microfluidics of the eccrine sweat gland, including biomarker partitioning, transport, and biosensing implications
Sonner, Z., Wilder, E., Heikenfeld, J., Kasting, G., Beyette, F., Swaile, D., Sherman, F., Joyce, J., Hagen, J., Kelley-Loughnane, N., et al. (2015) · Biomicrofluidics · doi:10.1063/1.4921039 · Cited by 724
Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents
Duman, R. S., & Voleti, B. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.004 · Cited by 714
Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)
Molendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A. A., Penninx, B. W. J. H., & Elzinga, B. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.105 · Cited by 702
The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
Maes, M., Leonard, B. E., Myint, A. M., Kubera, M., & Verkerk, R. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.017 · Cited by 700
Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression
Lamers, F., Vogelzangs, N., Merikangas, K. R., de Jonge, P., Beekman, A. T. F., & Penninx, B. W. J. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.144 · Cited by 691
Depressive disorders and immunity: 20 years of progress and discovery
Irwin, M. R., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.01.010 · Cited by 676
Inflammation and clinical response to treatment in depression: A meta-analysis
Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., & Cleare, A. J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.007 · Cited by 666
Self-citation
What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression
Gaynes, B. N., Warden, D., Trivedi, M. H., Wisniewski, S. R., Fava, M., & Rush, A. J. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1439 · Cited by 661
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
Maes, M., Berk, M., Goehler, L., Song, C., Anderson, G., Gałecki, P., & Leonard, B. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-66 · Cited by 629
The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?
Anacker, C., Zunszain, P. A., Carvalho, L. A., & Pariante, C. M. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.007 · Cited by 592
The Link between Thyroid Function and Depression
Hage, M. P., & Azar, S. T. (2012) · Journal of Thyroid Research · doi:10.1155/2012/590648 · Cited by 549
Is depression an inflammatory disorder?
Raison, C. L., & Miller, A. H. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0232-0 · Cited by 524
Neurocognitive impairment in drug-free patients with major depressive disorder
Porter, R. J., Gallagher, P., Thompson, J. M., & Young, A. H. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.3.214 · Cited by 519
Self-citation
Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology
Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.151 · Cited by 491
Toward understanding how early-life stress reprograms cognitive and emotional brain networks
Chen, Y., & Baram, T. Z. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.181 · Cited by 474
The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
Lee, B.-H., & Kim, Y. (2010) · Psychiatry Investigation · doi:10.4306/pi.2010.7.4.231 · Cited by 466
Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population
Srikanthan, K., Feyh, A., Visweshwar, H., Shapiro, J. I., & Sodhi, K. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.13800 · Cited by 458
Neuroendocrine aspects of hypercortisolism in major depression
Parker, K. J., Schatzberg, A. F., & Lyons, D. M. (2003) · Hormones and Behavior · doi:10.1016/s0018-506x(02)00016-8 · Cited by 455
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses
Bocchio-Chiavetto, L., Bagnardi, V., Zanardini, R., Molteni, R., Gabriela Nielsen, M., Placentino, A., Giovannini, C., Rillosi, L., Ventriglia, M., Riva, M. A., et al. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622971003611319 · Cited by 435
NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice
Walker, A. K., Budac, D. P., Bisulco, S., Lee, A. W., Smith, R. A., Beenders, B., Kelley, K. W., & Dantzer, R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.71 · Cited by 432
The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery
Dahl, J., Ormstad, H., Aass, H. C. D., Malt, U. F., Bendz, L. T., Sandvik, L., Brundin, L., & Andreassen, O. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.019 · Cited by 424
An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline
Uher, R., Tansey, K. E., Dew, T., Maier, W., Mors, O., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010094 · Cited by 418
Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways
Shishehbor, M. H., Brennan, M., Aviles, R. J., Fu, X., Penn, M. S., Sprecher, D. L., & Hazen, S. L. (2003) · Circulation · doi:10.1161/01.cir.0000080895.05158.8b · Cited by 403
Predictive neural biomarkers of clinical response in depression. a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies
Fu, C. H. Y., Steiner, H., & Costafreda, S. G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.008 · Cited by 399
Depression: an inflammatory illness?: Figure 1
Krishnadas, R., & Cavanagh, J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301779 · Cited by 392
Reproductive hormone sensitivity and risk for depression across the female life cycle: A continuum of vulnerability?
Soares, C. N., & Zitek, B. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0831 · Cited by 388
The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters
Aagaard, K., Petrosino, J., Keitel, W., Watson, M., Katancik, J., Garcia, N., Patel, S., Cutting, M., Madden, T., Hamilton, H., et al. (2013) · The FASEB Journal · doi:10.1096/fj.12-220806 · Cited by 383
A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers
Lopresti, A. L., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.017 · Cited by 371
Functional metabolomics: from biomarker discovery to metabolome reprogramming
Peng, B., Li, H., & Peng, X. (2015) · Protein & Cell · doi:10.1007/s13238-015-0185-x · Cited by 356
Brain-derived neurotrophic factor in mood disorders and antidepressant treatments
Castrén, E., & Kojima, M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.010 · Cited by 337
The heterogeneity of “major depression”
GOLDBERG, D. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00061.x · Cited by 335
Synaptic plasticity in depression: Molecular, cellular and functional correlates
Marsden, W. N. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.012 · Cited by 323
Association of depressive disorders, depression characteristics and antidepressant medication with inflammation
Vogelzangs, N., Duivis, H. E., Beekman, A. T. F., Kluft, C., Neuteboom, J., Hoogendijk, W., Smit, J. H., de Jonge, P., & Penninx, B. W. J. H. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.8 · Cited by 323
A systematic review and meta-analysis of the association between depression and insulin resistance
Kan, C., Silva, N., Golden, S. H., Rajala, U., Timonen, M., Stahl, D., & Ismail, K. (2013) · Diabetes Care · doi:10.2337/dc12-1442 · Cited by 322
The leptin hypothesis of depression: a potential link between mood disorders and obesity?
Lu, X.-Y. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.10.010 · Cited by 314
Depression, Antidepressants, and Neurogenesis: A Critical Reappraisal
Hanson, N. D., Owens, M. J., & Nemeroff, C. B. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.220 · Cited by 311
Serotonin receptors involved in antidepressant effects
Artigas, F. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.006 · Cited by 311
What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies
Fekadu, A., Wooderson, S. C., Markopoulo, K., Donaldson, C., Papadopoulos, A. S., & Cleare, A. J. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.10.014 · Cited by 306
Self-citation
Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways.
Maes, M. H. J., Kubera, M., Obuchowiczwa, E., Goehler, L. E., & Brzeszcz, J. (2011) · PubMed · Cited by 303
Biological embedding of stress through inflammation processes in childhood
Danese, A., Caspi, A., Williams, B., Ambler, A., Sugden, K., Mika, J., Werts, H., Freeman, J., Pariante, C. M., Moffitt, T. E., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.5 · Cited by 301
Polymorphisms in Inflammation-Related Genes Are Associated with Susceptibility to Major Depression and Antidepressant Response
Wong, M.-L., Dong, C., Maestre-Mesa, J., & Licinio, J. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.59 · Cited by 295
Cognitive Behavioral Therapy for Mood Disorders: Efficacy, Moderators and Mediators
Driessen, E., & Hollon, S. D. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.005 · Cited by 291
A detailed examination of cytokine abnormalities in Major Depressive Disorder
Simon, N. M., McNamara, K., Chow, C. W., Maser, R. S., Papakostas, G. I., Pollack, M. H., Nierenberg, A. A., Fava, M., & Wong, K. K. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.06.004 · Cited by 286
Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging
Lindqvist, D., Epel, E. S., Mellon, S. H., Penninx, B. W., Révész, D., Verhoeven, J. E., Reus, V. I., Lin, J., Mahan, L., Hough, C. M., et al. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.007 · Cited by 285
A Multidimensional Tool to Quantify Treatment Resistance in Depression
Fekadu, A., Wooderson, S. C., Donaldson, C., Markopoulou, K., Masterson, B., Poon, L., & Cleare, A. J. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04309 · Cited by 283
Self-citation
Neurobiological effects of exercise on major depressive disorder: A systematic review
Schuch, F. B., Deslandes, A. C., Stubbs, B., Gosmann, N. P., Silva, C. T. B. D., & Fleck, M. P. D. A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.11.012 · Cited by 279
A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity
Hiles, S. A., Baker, A. L., de Malmanche, T., & Attia, J. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.001 · Cited by 274
Inhibition of GSK3 by lithium, from single molecules to signaling networks
Freland, L., & Beaulieu, J. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00014 · Cited by 270
The common inflammatory etiology of depression and cognitive impairment: a therapeutic target
Allison, D. J., & Ditor, D. S. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0151-1 · Cited by 245
A psychoneuroimmunological review on cytokines involved in antidepressant treatment response
Janssen, D. G. A., Caniato, R. N., Verster, J. C., & Baune, B. T. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1103 · Cited by 240
Multi-omic data integration and analysis using systems genomics approaches: methods and applications in animal production, health and welfare
Suravajhala, P., Kogelman, L. J. A., & Kadarmideen, H. N. (2016) · Genetics Selection Evolution · doi:10.1186/s12711-016-0217-x · Cited by 232
The 5-HT1A receptor in Major Depressive Disorder
Kaufman, J., DeLorenzo, C., Choudhury, S., & Parsey, R. V. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.039 · Cited by 225
Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis
Hiles, S. A., Baker, A., de Malmanche, T., & Attia, J. (2012) · Psychological Medicine · doi:10.1017/s0033291712000128 · Cited by 224
Polygenic interactions with environmental adversity in the aetiology of major depressive disorder
Mullins, N., Power, R. A., Fisher, H. L., Hanscombe, K. B., Euesden, J., Iniesta, R., Levinson, D. F., Weissman, M. M., Potash, J. B., Shi, J., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715002172 · Cited by 224
Depressive symptoms and metabolic syndrome: is inflammation the underlying link?
Capuron, L., Su, S., Miller, A. H., Bremner, J. D., Goldberg, J., Vogt, G. J., Maisano, C., Jones, L., Murrah, N. V., & Vaccarino, V. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.019 · Cited by 219
Chronic interpersonal stress predicts activation of pro- and anti-inflammatory signaling pathways 6 months later
Miller, G. E., Rohleder, N., & Cole, S. W. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318190d7de · Cited by 197
Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: The prospective Sydney Memory and Aging Study
Baune, B., Smith, E., Reppermund, S., Air, T., Samaras, K., Lux, O., Brodaty, H., Sachdev, P. S., & Trollor, J. N. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.02.006 · Cited by 189
A meta-analysis of chemokines in major depression
Eyre, H. A., Air, T., Pradhan, A., Johnston, J., Lavretsky, H., Stuart, M. J., & Baune, B. T. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.006 · Cited by 188
The association between depressive symptoms, cognitive function, and inflammation in major depression
Krogh, J., Benros, M. E., Jørgensen, M. B., Vesterager, L., Elfving, B., & Nordentoft, M. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.08.014 · Cited by 185
Assessment of a Multi-Assay, Serum-Based Biological Diagnostic Test for Major Depressive Disorder: A Pilot and Replication Study
Papakostas, G. I., Shelton, R. C., Kinrys, G., Henry, M. E., Bakow, B. R., Lipkin, S. H., Pi, B., Thurmond, L., & Bilello, J. A. (2013) · Molecular Psychiatry · doi:10.1038/mp.2011.166 · Cited by 180
Studying depression using imaging and machine learning methods
Patel, M. J., Khalaf, A. M., & Aizenstein, H. J. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.11.003 · Cited by 179
The impact of childhood adversity on suicidality and clinical course in treatment-resistant depression
Tunnard, C., Rane, L. J., Wooderson, S. C., Markopoulou, K., Poon, L., Fekadu, A., Juruena, M. F., & Cleare, A. J. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.037 · Cited by 176
Self-citation
Biological Aspects of the Link between Smoking and Depression
Quattrocki, E., Baird, A., & Yurgelun-Todd, D. (2000) · Harvard Review of Psychiatry · doi:10.1080/hrp_8.3.99 · Cited by 176
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial
Arnow, B. A., Blasey, C., Williams, L. M., Palmer, D. M., Rekshan, W., Schatzberg, A. F., Etkin, A., Kulkarni, J., Luther, J. F., & Rush, A. J. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14020181 · Cited by 175
Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications
Rosenblat, J. D., Brietzke, E., Mansur, R. B., Maruschak, N. A., Lee, Y., & McIntyre, R. S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.058 · Cited by 172
The role of interleukin (IL)‐17 in anxiety and depression of patients with rheumatoid arthritis
Yang, L. I. U., Ho, R., & Mak, A. (2011) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2011.01673.x · Cited by 167
Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system
Carvalho, L. A., Torre, J. P., Papadopoulos, A. S., Poon, L., Juruena, M. F., Markopoulou, K., Cleare, A. J., & Pariante, C. M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.036 · Cited by 167
Self-citation
Antiglucocorticoid treatment of depression: double-blind ketoconazole
Wolkowitz, O. M., Reus, V. I., Chan, T., Manfredi, F., Raum, W. J., Johnson, R., & Canick, J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00267-4 · Cited by 165
The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models
Baune, B. T., Stuart, M. J., Gilmour, A., Wersching, H., Heindel, W. L., Arolt, V., & Berger, K. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.18 · Cited by 163
Genetic Determinants of Depression: Recent Findings and Future Directions
Dunn, E. C., Brown, R. C., Dai, Y., Rosand, J., Nugent, N. R., Amstadter, A. B., & Smoller, J. W. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000054 · Cited by 158
Role of inflammatory cytokines in depression: Focus on interleukin-1β
Farooq, R. K., Asghar, K., Kanwal, S., & Zulqernain, A. (2016) · Biomedical Reports · doi:10.3892/br.2016.807 · Cited by 158
VEGF as a potential target for therapeutic intervention in depression
Warner‐Schmidt, J. L., & Duman, R. S. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.10.013 · Cited by 156
The Efficacy of Omega-3 Supplementation for Major Depression
Lespérance, F., Frasure‐Smith, N., St-André, E., Turecki, G., Lespérance, P., & Wisniewski, S. R. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m05966blu · Cited by 149
Risk factors for treatment resistance in unipolar depression: A systematic review
Bennabi, D., Aouizerate, B., El‐Hage, W., Doumy, O., Molière, F., Courtet, P., Nieto, I., Bellivier, F., Bubrovsky, M., Vaïva, G., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.020 · Cited by 149
Plasma lipidomics reveals potential lipid markers of major depressive disorder
Liu, X., Li, J., Zheng, P., Zhao, X., Zhou, C., Hu, C., Hou, X., Wang, H., Xie, P., & Xu, G. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9768-5 · Cited by 148
Upregulation of blood proBDNF and its receptors in major depression
Zhou, L., Xiong, J., Lim, Y. P., Ruan, Y., Huang, C., Zhu, Y., Zhong, J., Xiao, Z., & Zhou, X. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.03.002 · Cited by 147
Inflammatory Biomarkers as Differential Predictors of Antidepressant Response
Hashimoto, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16047796 · Cited by 141
Variations in Circulating Cytokine Levels during 52 Week Course of Treatment with SSRI for Major Depressive Disorder
Hernández, M. E., Mendieta, D., Martínez-Fong, D., Loría, F., Moreno, J., Estrada, I., Bojalil, R., & Pavón, L. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.08.001 · Cited by 140
Adipokines as emerging depression biomarkers: A systematic review and meta-analysis
Carvalho, A. F., Rocha, D. Q. C., McIntyre, R. S., Mesquita, L. M., Köhler, C. A., Hyphantis, T. N., Sales, P. M. G., Machado‐Vieira, R., & Berk, M. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.08.002 · Cited by 138
The pharmacology of effort-related choice behavior: Dopamine, depression, and individual differences
Salamone, J. D., Correa, M., Yohn, S. E., López‐Cruz, L., Miguel, N. S., & Alatorre, L. F. (2016) · Behavioural Processes · doi:10.1016/j.beproc.2016.02.008 · Cited by 130
Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients
Cattaneo, A., Ferrari, C., Uher, R., Bocchio‐Chiavetto, L., Riva, M. A., & Pariante, C. M. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw045 · Cited by 130
The relationship between cortisol, stress and psychiatric illness: New insights using hair analysis
Herane Vives, A., De Angel, V., Papadopoulos, A., Strawbridge, R., Wise, T., Young, A. H., Arnone, D., & Cleare, A. J. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.08.007 · Cited by 129
Self-citation
Modulation of the mineralocorticoid receptor as add-on treatment in depression: A randomized, double-blind, placebo-controlled proof-of-concept study
Otte, C., Hinkelmann, K., Moritz, S., Yassouridis, A., Jahn, H., Wiedemann, K., & Kellner, M. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.10.006 · Cited by 129
The ratio of cortisol/DHEA in treatment resistant depression
Markopoulou, K., Papadopoulos, A. S., Juruena, M. F., Poon, L., Pariante, C. M., & Cleare, A. J. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.08.004 · Cited by 129
Self-citation
Risk factors for the bipolar and depression spectra
Angst, J., Gamma, A., & Endrass, J. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s418.4.x · Cited by 126
The Maudsley Staging Method for Treatment-Resistant Depression: Prediction of Longer-Term Outcome and Persistence of Symptoms
Fekadu, A., Wooderson, S. C., Markopoulou, K., & Cleare, A. J. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04728 · Cited by 125
Self-citation
Biochemical markers subtyping major depressive disorder
Kunugi, H., Hori, H., & Ogawa, S. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12299 · Cited by 120
Treatment response and cognitive impairment in major depression: Association with C-reactive protein
Chang, H. H., Lee, I. H., Gean, P. W., Lee, S.-Y., Chi, M. H., Yang, Y. K., Lu, R.-B., & Chen, P. S. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.07.239 · Cited by 120
Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale
Jacobsen, J. P. R., Krystal, A. D., Krishnan, K. R. R., & Caron, M. G. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.09.001 · Cited by 120
Neuroimmune and neuroendocrine abnormalities in depression: two sides of the same coin
Horowitz, M. A., & Zunszain, P. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12781 · Cited by 119
Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression
Diniz, B. S., Sibille, E., Ding, Y., Tseng, G., Aizenstein, H. J., Lotrich, F., Becker, J. T., Lopez, O. L., Lotze, M. T., Klunk, W. E., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.76 · Cited by 116
Cortisol as a predictor of psychological therapy response in depressive disorders: Systematic review and meta-analysis
Fischer, S., Strawbridge, R., Vives, A. H., & Cleare, A. J. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.180653 · Cited by 112
Self-citation
Sustained Low-Grade Pro-inflammatory State in Unmedicated, Remitted Women with Major Depressive Disorder as Evidenced by Elevated Serum Levels of the Acute Phase Proteins C-reactive Protein and Serum Amyloid A
Kling, M. A., Alesci, S., Csako, G., Costello, R., Luckenbaugh, D. A., Bonne, O., Duncko, R., Drevets, W. C., Manji, H. K., Charney, D. S., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.033 · Cited by 111
Ghrelin in psychiatric disorders – A review
Wittekind, D. A., & Kluge, M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.11.013 · Cited by 110
Fusing Data Mining, Machine Learning and Traditional Statistics to Detect Biomarkers Associated with Depression
Dipnall, J. F., Pasco, J. A., Berk, M., Williams, L. J., Dodd, S., Jacka, F. N., & Meyer, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148195 · Cited by 110
Diagnostic and therapeutic utility of neuroimaging in depression: an overview
Arnone, D., Wise, T., Cleare, A. J., Young, A. H., & Herane-Vives, A. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s50156 · Cited by 106
Self-citation
Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients
Stelzhammer, V., Haenisch, F., Chan, M. K., Cooper, J. D., Steiner, J., Steeb, H., Martins-de-Souza, D., Rahmoune, H., Guest, P. C., & Bahn, S. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000819 · Cited by 105
Decreased glial cell line-derived neurotrophic factor levels in patients with depression: A meta-analytic study
Lin, P., & Tseng, P. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.02.004 · Cited by 95
A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates
Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95
Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide
Isung, J., Mobarrez, F., Nordström, P., Åsberg, M., & Jokinen, J. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.624549 · Cited by 94
Treatment strategies to improve and sustain remission in major depressive disorder
Trivedi, M. H., & Daly, E. J. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/mhtrivedi · Cited by 91
High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania
Huang, T.-L., & Lin, F.-C. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.09.010 · Cited by 90
A Neurobiological Hypothesis of Treatment-Resistant Depression â€“ Mechanisms for Selective Serotonin Reuptake Inhibitor Non-Efficacy
Coplan, J. D., Gopinath, S., Abdallah, C. G., & Berry, B. R. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00189 · Cited by 90
Subclinical hypothyroidism, mood, and cognition in older adults: a review
Joffe, R. T., Pearce, E. N., Hennessey, J. V., Ryan, J. J., & Stern, R. A. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3796 · Cited by 88
Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis
Carvalho, A. F., Köhler, C. A., McIntyre, R. S., Knöchel, C., Brunoni, A. R., Thase, M. E., Quevedo, J., Fernandes, B. S., & Berk, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.07.002 · Cited by 88
CSF biomarkers in suicide attempters – a principal component analysis
Lindqvist, D., Janelidze, S., Erhardt, S., Träskman‐Bendz, L., Engström, G., & Brundin, L. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01655.x · Cited by 86
Predictors of response to antidepressants
Nierenberg, A. A. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00105-3 · Cited by 84
Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews
Mercier, A., Aubin-Auger, I., Lebeau, J., Schuers, M., Boulet, P., Hermil, J.-L., Royen, P. V., & Peremans, L. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-55 · Cited by 83
A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain
Popa, D., Cerdan, J., Repérant, C., Guiard, B. P., Guilloux, J., David, D. J. P., & Gardier, A. M. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.11.037 · Cited by 77
Prediction of longer-term outcome of treatment-resistant depression in tertiary care
Fekadu, A., Rane, L. J., Wooderson, S. C., Markopoulou, K., Poon, L., & Cleare, A. J. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.102665 · Cited by 77
Self-citation
Modulatory Effects of Antidepressant Classes on the Innate and Adaptive Immune System in Depression
Eyre, H. A., Lavretsky, H., Kartika, J., Qassim, A., & Baune, B. T. (2016) · Pharmacopsychiatry · doi:10.1055/s-0042-103159 · Cited by 77
Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response
Powell, T. R., Schalkwyk, L. C., Heffernan, A. L., Breen, G. D., Lawrence, T., Price, T., FARMER, A. E., Aitchison, K. J., Craig, I., Danese, A., et al. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.09.009 · Cited by 75
Discriminating Between Bipolar Disorder and Major Depressive Disorder
Vöhringer, P. A., & Perlis, R. H. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.10.001 · Cited by 74
Gene expression biomarkers of response to citalopram treatment in major depressive disorder
Mamdani, F., Berlim, M. T., Beaulieu, M.-M., Labbe, A., Mérette, C., & Turecki, G. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.12 · Cited by 72
Treatment strategies to improve and sustain remission in major depressive disorder.
Trivedi, M. H., & Daly, E. (2008) · Europe PMC (PubMed Central) · Cited by 70
Altered Chemokine Levels in the Cerebrospinal Fluid and Plasma of Suicide Attempters
Janelidze, S., Ventorp, F., Erhardt, S., Hansson, O., Minthon, L., Flax, J., Samuelsson, M., Traskman-Bendz, L., & Brundin, L. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.010 · Cited by 69
Possible contribution of IGF-1 to depressive disorder
Szczęsny, E., Ślusarczyk, J., Głombik, K., Budziszewska, B., Kubera, M., Lasoń, W., & Basta-Kaim, A. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71523-8 · Cited by 68
Superposição entre depressão atípica, doença afetiva sazonal e síndrome da fadiga crônica
Juruena, M. F., & Cleare, A. J. (2007) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462007000500005 · Cited by 68
Self-citation
Increased levels of vascular endothelial growth factor in patients with major depressive disorder: A meta-analysis
Tseng, P., Cheng, Y., Chen, Y., Wu, C.-K., & Lin, P. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.001 · Cited by 63
Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review
Tseng, P., Lin, P., Tu, K.-Y., Cheng, Y., Wu, C.-K., & Chen, Y. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s81432 · Cited by 63
Predictive diagnosis of major depression using NMR-based metabolomics and least-squares support vector machine
Zheng, H. X., Zheng, P., Zhao, L., Jia, J., Tang, S., Xu, P., Xie, P., & Gao, H. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.11.039 · Cited by 60
The macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90266-2 · Cited by 60
Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds
Fornaro, M., Rocchi, G., Escelsior, A., Contini, P., & Martino, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.08.007 · Cited by 59
Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies
Thase, M. E. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/mthase · Cited by 57
Effect of Oral and Vaginal Hormonal Contraceptives on Inflammatory Blood Biomarkers
Divani, A. A., Luo, X., Datta, Y. H., Flaherty, J. D., & Panoskaltsis‐Mortari, A. (2015) · Mediators of Inflammation · doi:10.1155/2015/379501 · Cited by 56
Elevation of plasma concentration of adhesion molecules in late‐life depression
Dimopoulos, N. P., Piperi, C., Salonicioti, A., Mitsonis, C., Liappas, I., Lea, R. W., & Kalofoutis, A. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1592 · Cited by 54
Elevated C-reactive protein in depression: a predictor of good long-term outcome with antidepressants and poor outcome with psychotherapy
Harley, J., Luty, S., Carter, J., Mulder, R., & Joyce, P. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109102770 · Cited by 53
Neurocognitive Function Following Remission in Major Depressive Disorder: Potential Objective Marker of Response?
Gallagher, P., Robinson, L. J., Gray, J. M., Young, A. H., & Porter, R. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670601057734 · Cited by 52
Self-citation
Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications
Gallagher, P., & Young, A. H. (2006) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a811 · Cited by 48
Self-citation
Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial
McAllister-Williams, R. H., Anderson, I. M., Finkelmeyer, A., Gallagher, P., Grunze, H. C. R., Haddad, P. M., Hughes, T., Lloyd, A. J., Mamasoula, C., McColl, E., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00436-8 · Cited by 47
Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls
Tu, K.-Y., Wu, M., Chen, Y., Lin, P., Wang, H., Wu, C.-K., & Tseng, P. (2016) · Medicine · doi:10.1097/md.0000000000002411 · Cited by 46
Variation in serum biomarkers with sex and female hormonal status: implications for clinical tests
Ramsey, J. M., Cooper, J. D., Penninx, B. W. J. H., & Bahn, S. (2016) · Scientific Reports · doi:10.1038/srep26947 · Cited by 45
Neurotrophic factors in depression in response to treatment
Buttenschøn, H. N., Foldager, L., Elfving, B., Poulsen, P. H. P., Uher, R., & Mors, O. N. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.05.027 · Cited by 44
Fear Biases in Emotional Face Processing Following Childhood Trauma as a Marker of Resilience and Vulnerability to Depression
Suzuki, A., Poon, L., Kumari, V., & Cleare, A. J. (2015) · Child Maltreatment · doi:10.1177/1077559515600781 · Cited by 43
Self-citation
Vascular endothelial growth factor: Potential predictor of treatment response in major depression
Clark-Raymond, A., Meresh, E. S., Hoppensteadt, D., Fareed, J., Sinacore, J. M., Garlenski, B., & Halaris, A. E. (2016) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1117655 · Cited by 42
Differential Responses to Psychotherapy Versus Pharmacotherapy in Patients With Chronic Forms of Major Depression and Childhood Trauma
Nemeroff, C. B., Heim, C. M., Thase, M. E., Klein, D. N., Rush, A. J., Schatzberg, A. F., Ninan, P. T., McCullough, J. P., Weiss, P. M., Dünner, D. L., et al. (2005) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.3.1.131 · Cited by 41
Bidirectional Association Between Depression and Metabolic Syndrome A systematic review and meta-analysis of epidemiological studies
Pan, A., Keum, N., Okereke, O., et al. (2012) · UCL Discovery (University College London) · Cited by 40
Plasma Levels of Catecholamine Metabolites Predict the Response to Sulpiride or Fluvoxamine in Major Depression
Ueda, N., Yoshimura, R., Shinkai, K., & Nakamura, J. (2002) · Pharmacopsychiatry · doi:10.1055/s-2002-34116 · Cited by 39
Decreased serum fibroblast growth factor - 2 levels in pre- and post-treatment patients with major depressive disorder
Shen, H., Zhang, T., Hong, B., Peng, D., Su, H. L., Lin, Z., Fang, Y., Jiang, K., Liu, X., & Li, H. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.07.035 · Cited by 39
Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers
Jani, B., McLean, G., Nicholl, B. I., Barry, S., Sattar, N. A., Mair, F. S., & Cavanagh, J. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00018 · Cited by 39
The use of statins for the treatment of depression in patients with acute coronary syndrome
Kim, S. W., Bae, K., Kim, J.-M., Shin, I., Hong, Y. J., Ahn, Y., Jeong, M. H., Berk, M., & Yoon, J. S. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.116 · Cited by 38
Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review
Yoshimura, R., Nakamura, J., Shinkai, K., & Ueda, N. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.01.008 · Cited by 38
Disturbances in Hypothalamic-Pituitary-Adrenal Axis and Immunological Activity Differentiating between Unipolar and Bipolar Depressive Episodes
Becking, K., Spijker, A. T., Hoencamp, E., Penninx, B. W. J. H., Schoevers, R. A., & Boschloo, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133898 · Cited by 36
Significantly higher peripheral fibroblast growth factor-2 levels in patients with major depressive disorder
Wu, C.-K., Tseng, P., Chen, Y., Tu, K.-Y., & Lin, P. (2016) · Medicine · doi:10.1097/md.0000000000004563 · Cited by 35
Chronobiological hypothalamic–pituitary–thyroid axis status and antidepressant outcome in major depression
Duval, F., Mokrani, M., Erb, A., Lopera, F. G., Alexa, C., Proudnikova, X., & Butucaru, I. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.05.005 · Cited by 33
Genetic biomarkers of depression
Tamatam, A., Bawa, A. S., & Khanum, F. (2012) · Indian journal of human genetics · doi:10.4103/0971-6866.96639 · Cited by 32
No health without mental health
Vladu, C., Novac, A., Preda, A., & Bota, R. G. (2016) · Mental Illness · doi:10.4081/mi.2016.6609 · Cited by 31
Big Data in mental health: a challenging fragmented future
Hidalgo‐Mazzei, D., Murru, A., Reinares, M., Vieta, E., & Colom, F. (2016) · World Psychiatry · doi:10.1002/wps.20307 · Cited by 30
Biological Aspects of the Link between Smoking and Depression
Quattrocki, E. (2000) · Harvard Review of Psychiatry · doi:10.1093/hrp/8.3.99 · Cited by 28
Clinical prediction of antidepressant response in mood disorders: Linear multivariate vs. neural network models
Serretti, A., Olgiati, P., Liebman, M., Hu, H., Zhang, Y., Zanardi, R., Colombo, C., & Smeraldi, E. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.07.009 · Cited by 27
Detection of bipolar disorder
Young, A. H., & MacPherson, H. (2011) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.110.089128 · Cited by 26
Self-citation
Gene expression: Biomarker of antidepressant therapy?
Menke, A. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.825580 · Cited by 25
A rest-activity biomarker to predict response to SSRIs in major depressive disorder
McCall, W. V. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.02.023 · Cited by 24
Soluble Intracellular Adhesion Molecule-1 in Patients with Unipolar or Bipolar Affective Disorders: Results from a Pilot Trial
Schaefer, M., Sarkar, S., Schwarz, M., & Friebe, A. (2016) · Neuropsychobiology · doi:10.1159/000446919 · Cited by 21
Inflammation and treatment resistance in major depression: The perfect storm
Raison, C. L., Felger, J. C., & Miller, A. H. (2013) · The Psychiatric times · Cited by 21
Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder
Atake, K., Yoshimura, R., Hori, H., Katsuki, A., Ikenouchi, A., Umene‐Nakano, W., & Nakamura, J. (2014) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2014.12.1.37 · Cited by 15
Increased funding needed for mental health research
Kingdon, D., & Wykes, T. (2013) · BMJ · doi:10.1136/bmj.f402 · Cited by 12
Discovery of metabolite biomarkers: flux analysis and reaction-reaction network approach
Li, L., Jiang, H., Qiu, Y., Ching, W., & Vassiliadis, V. S. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-s2-s13 · Cited by 11

Research works printed but not linked: 2

Krishnadas R, Cavanagh J. Depression: an inflammatory illness? J Neurol Neurosurg Psychiatry. 2012;83(5):495-502.
Xia Q, Wang G, Wang H, Xie Z, Fang Y, Li Y. Study of metabolism of glucose and lipid in patients of first-episode depressioon. J Clin Psychiatry. 2009;19:241-243.

Sorted by citations

Sleep, insomnia, and depression
Riemann, D. W., Krone, L. B., Wulff, K., & Nissen, C. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0411-y · Cited by 901
Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model-Are we there yet?
Jesulola, E., Micalos, P., & Baguley, I. J. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.025 · Cited by 379
Biological Sex Differences in Depression: A Systematic Review
Labaka, A., Goñi‐Balentziaga, O., Lebeña, A., & Pérez-Tejada, J. (2018) · Biological Research For Nursing · doi:10.1177/1099800418776082 · Cited by 297
Impact of COVID-19 in the Mental Health in Elderly: Psychological and Biological Updates
Grolli, R. E., Mingoti, M. E. D., Bertollo, A. G., Luzardo, A. R., Quevedo, J., Réus, G. Z., & Ignácio, Z. M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02249-x · Cited by 286
Heart Rate Variability as Indicator of Clinical State in Depression
Hartmann, R., Schmidt, F. M., Sander, C., & Hegerl, U. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00735 · Cited by 262

See all 444

Authors: Strawbridge, R., Young, A. H., & Cleare, A. J.
Affiliations: King's College London (GB)
Corresponding author: Strawbridge, Rebecca
ORCID: Strawbridge, Rebecca
Young, Allan H
Cleare, Anthony J
Venue: Neuropsychiatric Disease and Treatment
Publisher: Informa UK Limited
Published: 2017-05
Volume: Volume 13
Pages: 1245-1262
ISSN: 1176-6328 (ISSN-L)
1178-2021
DOI: 10.2147/ndt.s114542
OpenAlex: W3141564337
Cited by: 415
References: 212
Citations by year: 2026: 35 · 2025: 55 · 2024: 57 · 2023: 36 · 2022: 38 · 2021: 55 · 2020: 50 · 2019: 40 · 2018: 43 · 2017: 5
FWCI: 4.79
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by-nc
creativecommons.org/licenses/by-nc/3.0/ (unspecified)
Locations: Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
Research Portal (King's College London) (submittedVersion, cc-by-nc)
Funders: South London and Maudsley NHS Foundation Trust
Wellcome Trust
National Institute for Health and Care Research (NF-SI-0616-10091)
King's College London
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords: depression biomarkers, major depressive disorder, inflammation, neurotrophic factors, metabolic biomarkers, neurotransmitters, neuroendocrine system, epigenetics, transcriptomics, proteomics, metabolomics, neuroimaging, treatment response prediction, patient stratification, personalized medicine, depression heterogeneity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Biomarkers for depression: recent insights, current challenges and future prospects

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks